Chargement en cours...
FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors
Fetal hemoglobin (HbF) improves the clinical severity of sickle cell disease (SCD), therefore, research to identify HbF-inducing agents for treatment purposes is desirable. The focus of our study is to investigate the ability of FK228 analogues to induce HbF using a novel KU812 dual-luciferase repor...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3359661/ https://ncbi.nlm.nih.gov/pubmed/22655179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/428137 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|